Trial Profile
MENVEO Pregnancy Registry: an Observational Study on the Safety of MENVEO Exposure in Pregnant Women and Their Offspring
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 28 Jun 2023
Price :
$35
*
At a glance
- Drugs Meningococcal vaccine groups A C Y W-135 conjugate (Primary)
- Indications Meningococcal infections
- Focus Adverse reactions
- Sponsors GlaxoSmithKline; GSK; Novartis
- 01 Jun 2018 Status changed from active, no longer recruiting to completed.
- 24 Oct 2017 Status changed from recruiting to active, no longer recruiting.
- 30 Dec 2014 Planned End Date changed from 1 Feb 2019 to 1 Aug 2018 as reported by ClinicalTrials.gov record.